Cite
HARVARD Citation
Inzoli, E. et al. (2022). Tyrosine Kinase Inhibitor discontinuation in Chronic Myeloid Leukemia: eligibility criteria and predictors of success. American journal of hematology. 97 (8), pp. 1075-1085. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Inzoli, E. et al. (2022). Tyrosine Kinase Inhibitor discontinuation in Chronic Myeloid Leukemia: eligibility criteria and predictors of success. American journal of hematology. 97 (8), pp. 1075-1085. [Online].